Evidence map›Paper›PMID 38509496›Full record

ArticleBMC public health2024

Prevalence and factors associated with hepatitis b vaccination uptake and completion among communities targeted for mass vaccination in gulu: a cross-sectional study.

Andrew Kimera, Lynn Atuyambe, Huzaifa Mutyaba, Claire Nantongo, Agnes Namagembe, Anna Maria Nalumansi, Andrew Basenero, Prisca Auma, Nelson Mukiza, Joan Mutyoba

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Andrew KimeraMakerere University College of Health Sciences, Kampala, Uganda. akimera88a@gmail.com.
Lynn AtuyambeMakerere University College of Health Sciences, Kampala, Uganda.
Huzaifa MutyabaMakerere University College of Health Sciences, Kampala, Uganda.
Claire NantongoMakerere University College of Health Sciences, Kampala, Uganda.
Agnes NamagembeMakerere University College of Health Sciences, Kampala, Uganda.
Anna Maria NalumansiMakerere University College of Health Sciences, Kampala, Uganda.
Andrew BaseneroRineCynth Advisory Limited, Kampala, Uganda.
Prisca AumaRineCynth Advisory Limited, Kampala, Uganda.
Nelson MukizaRineCynth Advisory Limited, Kampala, Uganda.
Joan MutyobaMakerere University College of Health Sciences, Kampala, Uganda.
Makerere University · UG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatitis B virus (HBV) is associated with several acute and long-term complications and vaccination is the cornerstone of prevention. A recent outbreak in Gulu, Uganda, one of the districts covered by a mass vaccination campaign, suggests low uptake of HBV vaccination. This study aims to determine the uptake and completion of HBV vaccination and associated factors among residents of Gulu, Uganda.

methodsA mixed methods cross-sectional study was conducted in Gulu, Northern Uganda, among 434 adult residents. A pretested questionnaire was used to collect data on socio-demographics, perceptions, and knowledge of HBV vaccination. Modified Poisson regression analysis was used in STATA 14 software to obtain prevalence ratios for the association between the independent and dependent variables. For qualitative data, 9 key informant interviews were conducted and thematic analysis was done using Quirkos software.

resultsOut of the 434 respondents, 41.9% had received at least one dose of the hepatitis B vaccine, 32.5% had received at least 2 doses, and only 20% had completed all 3 doses, with an overall completion rate of 47.8% for participants who had been initiated on the vaccine. Gender, residence, risk perception of Hepatitis B infection, perceived safety of the vaccine, and awareness of mass vaccination were associated with uptake of Hepatitis B vaccination. Residence, knowledge, and perception of being at risk of acquiring Hepatitis B were associated with completion. Qualitative results revealed that the levels of uptake and completion could have been affected by access to vaccination sites; inadequate knowledge about the disease; myths about the vaccine and inadequate community engagement.

conclusionLow Hepatitis B vaccine uptake and completion rates were observed in Gulu. To enhance vaccination coverage, future initiatives should prioritize awareness, education, and dispelling of vaccination myths. Additionally, increased government investment in training health workers can serve as a valuable strategy to improve information dissemination and awareness among the population.

Indexed as

Hepatitis BHepatitis B VaccinesAdultCross-Sectional StudiesHepatitis B virusHumansMass VaccinationPrevalenceUgandaVaccinationHepatitis B VaccinesHepatitis BHepatitis B vaccinationMass vaccination

Identifiers

PMID38509496
PMCPMC10956285
OpenAlexW4392982608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.